Chongqing Lummy Pharmaceutical Co., Ltd. logo

Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
5. 32
-0.03
-0.5607%
¥
5.7B Market Cap
- P/E Ratio
0.2% Div Yield
41.99M Volume
- Eps
¥ 5.35
Previous Close
Add Transaction
Day Range
5.22 5.46
Year Range
4.1 6.86
Want to track 300006 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300006 closed today lower at ¥5.32, a decrease of -0.5607% from yesterday's close, completing a monthly increase of 2.3077% or ¥0.12. Over the past 12 months, 300006 stock gained 3.5019%.
300006 is not paying dividends to its shareholders.
The last earnings report, released on Apr 11, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0069%, based on the last three reports.
Chongqing Lummy Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 24, 2016.
The company's stock is traded on one exchange.

300006 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Chongqing Lummy Pharmaceutical Co., Ltd. (300006) FAQ

What is the stock price today?

The current price is ¥5.32.

On which exchange is it traded?

Chongqing Lummy Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300006.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.2%.

What is its market cap?

As of today, the market cap is 5.7B.

Has Chongqing Lummy Pharmaceutical Co., Ltd. ever had a stock split?

Chongqing Lummy Pharmaceutical Co., Ltd. had 2 splits and the recent split was on May 24, 2016.

Chongqing Lummy Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Rongzhao Qiu CEO
XSHE Exchange
CNE100000H10 ISIN
CN Country
1,019 Employees
3 Jul 2020 Last Dividend
24 May 2016 Last Split
30 Oct 2009 IPO Date

Overview

Chongqing Lummy Pharmaceutical Co., Ltd. is a prominent pharmaceutical company founded in 1999 and based in Chongqing, China. The company is dedicated to the research and development, manufacture, and distribution of a wide range of pharmaceutical products within the Chinese market. With a focus on addressing a vast spectrum of healthcare needs, Chongqing Lummy Pharmaceutical Co., Ltd. has established a significant presence in the pharmaceutical industry, offering solutions in numerous therapeutic areas from antibacterial treatments to nutritional supplements.

Products and Services

  • Antibacterial, Antifungal, Antiviral Agents

    These products are designed to treat various infections caused by bacteria, fungi, and viruses, playing a crucial role in managing infectious diseases.

  • Acid-Base Balance Nutritional Products

    This category includes supplements and medications intended to maintain or restore the body's ideal pH balance, thereby supporting overall health and well-being.

  • Liver Auxiliary Drugs

    These products are formulated to support liver health and function, essential for detoxifying the body and metabolizing substances.

  • Chinese Patent Drugs

    Traditional Chinese Medicine (TCM) formulations that offer a range of therapeutic benefits, based on centuries-old knowledge and practices.

  • Base Large Infusion Drugs

    These are intravenous solutions administered to provide essential nutrients, treat dehydration, or serve as vehicles for other medications.

  • American Ginseng

    A natural herbal supplement known for its antioxidant and energizing properties, often used to enhance physical and mental well-being.

  • Drugs for the Treatment of Tumors

    These oncology products are aimed at treating various types of cancer, employing different mechanisms to inhibit tumor growth and spread.

  • Drugs for Digestive, Immune, Blood, Nervous, Cardiovascular, and Endocrinology Systems

    A broad range of medications targeting diseases and conditions affecting the digestive, immune, hematologic, nervous, cardiovascular, and endocrine systems, addressing a wide array of health issues.

  • Sodium Bicarbonate Injection

    A solution used in medical emergencies to correct acidosis and to treat conditions requiring an increase in plasma bicarbonate concentrations.

Contact Information

Address: Building B, Huangshan Avenue, Chongqing, China, 401121
Phone: 86 23 6730 0395